Delivery Order SPE2DB20D2001-SPE2DB25FPLLS

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.59, is for the delivery of ULORIC 40 MG TABLET 30S, a medication used to treat gout. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,158.48 firm fixed-price delivery order is for the supply of ULORIC 80 MG TABLET 30S, a generic pharmaceutical product. The contract has a completion date of June 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,442.07, is a Delivery Order for the supply of ULORIC 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025 and a firm fixed price pricing type. This award is not designated as a set-aside contract. The contract appears to be part of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ULORIC 40 MG TABLET 30S. The order, valued at $3,321.78, is a firm fixed-price contract with an ultimate completion date of October 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,039.85, is for the delivery of Uloric 40 mg tablets. The contract is a firm-fixed-price, Indefinite Delivery Contract (IDC) that runs through August 15, 2022. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ULORIC 40 MG TABLET 30S. The fixed-price contract has a ceiling value of $2,077.25 and runs through November 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has no set-aside designation, indicating open competition. This delivery order is likely part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,810.20, is for the delivery of 4563458673 ULORIC 40 MG TABLET 30S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The award has an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564450183 ULORIC 40 MG TABLET 30S. The $2,802.33 firm-fixed-price contract has a completion date of May 1, 2024 and was awarded on April 30, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This federal contract award, with the ID SPE2DB20D3103|SPE2DB24FQ3M5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4565862279 ULORIC 40 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,621.50 and a completion date of September 19, 2024. This is a firm fixed-price delivery order contract, and no set-aside was used. Amerisourcebergen, a major pharmaceutical...
This federal contract award, identified as SPE2DB20D2104|SPE2DB24FU92F, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,167.06 firm fixed-price delivery order is for the pharmaceutical product Uloric 40 mg tablet 30s. The contract has an ultimate completion date of June 28, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov)....
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB25FPLLS
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Uloric 80 mg tablets, a medication used to treat gout. The contract has a firm fixed price of $1,272.84 and a completion date of November 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:41 AM